Literature DB >> 19843693

HPV E6 protein interacts physically and functionally with the cellular telomerase complex.

Xuefeng Liu1, Aleksandra Dakic, Yiyu Zhang, Yuhai Dai, Renxiang Chen, Richard Schlegel.   

Abstract

Telomerase activation is critical for the immortalization of primary human keratinocytes by the high-risk HPV E6 and E7 oncoproteins, and this activation is mediated in part by E6-induction of the hTERT promoter. E6 induces the hTERT promoter via interactions with the cellular ubiquitin ligase, E6AP, and with the c-Myc and NFX-1 proteins, which are resident on the promoter. In the current study we demonstrate that E6 protein interacts directly with the hTERT protein. Correlating with its ability to bind hTERT, E6 also associates with telomeric DNA and with endogenous active telomerase complexes. Most importantly, E6 increases the telomerase activity of human foreskin fibroblasts transduced with the hTERT gene, and this activity is independent of hTERT mRNA expression. Unlike its ability to degrade p53, E6 does not degrade hTERT protein in vitro or in vivo. Our studies of E6/hTERT interactions also reveal that the C-terminal tagged hTERT protein, although incapable of immortalizing fibroblasts, does immortalize keratinocytes in collaboration with the viral E7 protein. Thus, E6 protein mediates telomerase activation by a posttranscriptional mechanism and these findings provide a model for exploring the direct modulation of cell telomerase/telomere function by an oncogenic virus and suggest its potential role in both neoplasia and virus replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843693      PMCID: PMC2773972          DOI: 10.1073/pnas.0906357106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis.

Authors:  Janine Hertzog Santos; Joel N Meyer; Bennett Van Houten
Journal:  Hum Mol Genet       Date:  2006-04-13       Impact factor: 6.150

2.  Regulation of telomerase by human papillomaviruses.

Authors:  D A Galloway; L C Gewin; H Myers; W Luo; C Grandori; R A Katzenellenbogen; J K McDougall
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

3.  Telomerase activity does not always imply telomere maintenance.

Authors:  M M Ouellette; D L Aisner; I Savre-Train; W E Wright; J W Shay
Journal:  Biochem Biophys Res Commun       Date:  1999-01-27       Impact factor: 3.575

4.  Inhibition of telomerase limits the growth of human cancer cells.

Authors:  W C Hahn; S A Stewart; M W Brooks; S G York; E Eaton; A Kurachi; R L Beijersbergen; J H Knoll; M Meyerson; R A Weinberg
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

5.  The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.

Authors:  Xuefeng Liu; Hang Yuan; Baojin Fu; Gary L Disbrow; Tania Apolinario; Vjekoslav Tomaic; Melissa L Kelley; Carl C Baker; Jon Huibregtse; Richard Schlegel
Journal:  J Biol Chem       Date:  2005-01-17       Impact factor: 5.157

6.  The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase.

Authors:  Melissa L Kelley; Kerri E Keiger; Chan Jae Lee; Jon M Huibregtse
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.

Authors:  H Zimmermann; R Degenkolbe; H U Bernard; M J O'Connor
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300.

Authors:  Michael A James; John H Lee; Aloysius J Klingelhutz
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

9.  Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.

Authors:  Xuefeng Liu; Gary L Disbrow; Hang Yuan; Vjekoslav Tomaic; Richard Schlegel
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

10.  TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program.

Authors:  Jinkuk Choi; Lucinda K Southworth; Kavita Y Sarin; Andrew S Venteicher; Wenxiu Ma; Woody Chang; Peggie Cheung; Sohee Jun; Maja K Artandi; Naman Shah; Stuart K Kim; Steven E Artandi
Journal:  PLoS Genet       Date:  2007-12-13       Impact factor: 5.917

View more
  50 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Authors:  Monique A Morrison; Richard J Morreale; Shailaja Akunuru; Matthew Kofron; Yi Zheng; Susanne I Wells
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 3.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

4.  Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.

Authors:  Shiyuan Hong; Kavi P Mehta; Laimonis A Laimins
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

5.  Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.

Authors:  Marcel Chris Conrady; Irina Suarez; Gergö Gogl; Desiree Isabella Frecot; Anna Bonhoure; Camille Kostmann; Alexandra Cousido-Siah; André Mitschler; JiaWen Lim; Murielle Masson; Thomas Iftner; Frank Stubenrauch; Gilles Travé; Claudia Simon
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

6.  The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.

Authors:  Sawali R Sudarshan; Richard Schlegel; Xuefeng Liu
Journal:  Biochem Biophys Res Commun       Date:  2010-08-03       Impact factor: 3.575

7.  ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells.

Authors:  Xuefeng Liu; Virginie Ory; Sandra Chapman; Hang Yuan; Chris Albanese; Bhaskar Kallakury; Olga A Timofeeva; Caitlin Nealon; Aleksandra Dakic; Vera Simic; Bassem R Haddad; Johng S Rhim; Anatoly Dritschilo; Anna Riegel; Alison McBride; Richard Schlegel
Journal:  Am J Pathol       Date:  2011-12-18       Impact factor: 4.307

Review 8.  [Invasion and metastasis mechanism of human papillomavirus in head and neck squamous cell carcinomas].

Authors:  Guang-Xue Cui; Xiao-Lei Gao; Xin-Hua Liang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-10-01

9.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.

Authors:  Patrick J Killela; Zachary J Reitman; Yuchen Jiao; Chetan Bettegowda; Nishant Agrawal; Luis A Diaz; Allan H Friedman; Henry Friedman; Gary L Gallia; Beppino C Giovanella; Arthur P Grollman; Tong-Chuan He; Yiping He; Ralph H Hruban; George I Jallo; Nils Mandahl; Alan K Meeker; Fredrik Mertens; George J Netto; B Ahmed Rasheed; Gregory J Riggins; Thomas A Rosenquist; Mark Schiffman; Ie-Ming Shih; Dan Theodorescu; Michael S Torbenson; Victor E Velculescu; Tian-Li Wang; Nicolas Wentzensen; Laura D Wood; Ming Zhang; Roger E McLendon; Darell D Bigner; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Hai Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

10.  High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells.

Authors:  Timothy M Chlon; Elizabeth E Hoskins; Christopher N Mayhew; Kathryn A Wikenheiser-Brokamp; Stella M Davies; Parinda Mehta; Kasiani C Myers; James M Wells; Susanne I Wells
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.